Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19.

PHASE2RecruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

February 17, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

October 31, 2027

Conditions

Nervous System Diseases

Interventions

DRUG

Tianeptine

Tianesal 12,5mg

DRUG

Placebo

application as in the control group

Trial Locations (1)

RECRUITING

Anna Klimkiewicz, Warsaw